American Journal of Clinical Nutrition, Vol 54, 578-585, Copyright © 1991 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention

MS Marcus, SA Sondel, PM Farrell, A Laxova, PM Carey, R Langhough and EH Mischler
Department of Pediatrics, University of Wisconsin, Madison.

The purpose of this study was to characterize the nutritional status of infants diagnosed with cystic fibrosis (CF) through neonatal screening and to determine if they would achieve normal nutrition when managed with early intervention. In addition, nutrient intake was assessed to determine energy and macronutrient-consumption patterns. Evaluation of growth revealed that normal patterns could be achieved with mean energy intake values at ages 6 and 12 mo of 481 and 426 kJ/kg body wt (115 and 102 kcal/kg body wt), respectively. Biochemical assessment demonstrated low alpha-tocopherol and linoleic acid values at diagnosis in the majority of infants whereas one-third had abnormal indices of protein nutriture. Essential fatty acid deficiency was also demonstrated at diagnosis by abnormal triene-tetraene ratio values in 27% of screened infants. With predigested formula and dietary supplementation, there was improvement in all indices of nutritional status and only a low percentage of patients showed mild biochemical abnormalities at age 12 mo.

This article has been cited by other articles:

				S. M. Shoff, H.-Y. Ahn, L. Davis, H. Lai, and the Wisconsin CF Neonatal Screening Group Temporal Associations Among Energy Intake, Plasma Linoleic Acid, and Growth Improvement in Response to Treatment Initiation After Diagnosis of Cystic Fibrosis Pediatrics, February 1, 2006; 117(2): 391 - 400. [Abstract] [Full Text] [PDF]

				R. L. Koscik, P. M. Farrell, M. R. Kosorok, K. M. Zaremba, A. Laxova, H.-C. Lai, J. A. Douglas, M. J. Rock, and M. L. Splaingard Cognitive Function of Children With Cystic Fibrosis: Deleterious Effect of Early Malnutrition Pediatrics, June 1, 2004; 113(6): 1549 - 1558. [Abstract] [Full Text] [PDF]

				P. M. Farrell, M. R. Kosorok, M. J. Rock, A. Laxova, L. Zeng, H.-C. Lai, G. Hoffman, R. H. Laessig, M. L. Splaingard, and the Wisconsin Cystic Fibrosis Neonatal Screening S Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth Pediatrics, January 1, 2001; 107(1): 1 - 13. [Abstract] [Full Text]

				H.-C. Lai, M. R. Kosorok, A. Laxova, L. A. Davis, S. C. FitzSimmon, and P. M. Farrell Nutritional Status of Patients With Cystic Fibrosis With Meconium Ileus: A Comparison With Patients Without Meconium Ileus and Diagnosed Early Through Neonatal Screening Pediatrics, January 1, 2000; 105(1): 53 - 61. [Abstract] [Full Text] [PDF]

				D. L Waters, B. Wilcken, L. Irwig, P. Van Asperen, C. Mellis, J. M Simpson, J. Brown, and K. J Gaskin Clinical outcomes of newborn screening for cystic fibrosis Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1999; 80(1): 1F - 7. [Abstract] [Full Text]

				P. M. Farrell, M. R. Kosorok, A. Laxova, G. Shen, R. E. Koscik, W. T. Bruns, M. Splaingard, E. H. Mischler, and The Wisconsin Cystic Fibrosis Neonatal Screening S Nutritional Benefits of Neonatal Screening for Cystic Fibrosis N. Engl. J. Med., October 2, 1997; 337(14): 963 - 969. [Abstract] [Full Text] [PDF]

				B. S. Wilfond, P. M. Farrell, A. Laxova, and E. Mischler Severe Hemolytic Anemia Associated With Vitamin E Deficiency in Infants With Cystic Fibrosis: Implications for Neonatal Screening Clinical Pediatrics, January 1, 1994; 33(1): 2 - 7. [Abstract] [PDF]